Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing injection added to antibiotics for fever in community-acquired pneumonia
ChiCTR1900022635Phase 4Recruiting
- Sponsor
- PLA 967th Hospital
- Start
- Apr 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tanreqing in community-acquired pneumonia (CAP) (2 arms), sponsored by PLA 967th Hospital. Primary endpoint: Time to fever relief. Started Apr 2019; status: recruiting.
02
Drugs
tanreqing
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR1900022635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022635.